ORDER NOW

KNOWLEDGE CENTER

FREQUENTLY ASKED QUESTIONS

PRODUCT/
BENEFITS

FAQs

REFERENCES

DEVICE
TRAINING

PROVIDER
VIDEOS

REIMBURSEMENT

What is NovoPulse® MKX-1?

NovoPulse® MKX-1 is FDA-approved as a Class I device for pain management. It is a Transcutaneous Electrical Joint Stimulation Device that delivers a deep three-dimensional electric field directly into the spinal or articular joints, interacting with the articular cartilage to promote positive cartilage rejuvenation, reduce pain, decrease inflammation, and enhance functional mobility.

What is the primary indication for the use of NovoPulse® MKX-1?
Pain from injuries to articular joints of the body may result in acute or chronic pain and osteoarthritis.
How is the NovoPulse® MKX-1 best used?
Thirty minutes each day for 90 days over the region of involvement.
Will prior authorization be needed before use of NovoPulse® MKX-1 is reimbursed?
Possibly. Please check with the patient’s health plan for more details regarding their prior authorization process. This product may require the use of a Certificate of Medical Need or a payer-specific Prior Authorization form.
When should the patient be scheduled for follow-up with the use of NovoPulse® MKX-1?
Schedule patients within 90 days to verify the continuing need for the NovoPulse® MKX-1® for the patient’s pain and/or condition, as it pertains to your Plan of Care. The patient’s progress should be assessed at 30, 60, and 90 days with a face to face or telehealth service re-evaluations to determine the patient’s response to care and the need for further treatment.
How do I order this product?

Contact us at order@Novo-Pulse.com or call 952-893-1700.

How will the patient be instructed on the use of the NovoPulse® MKX-1?

The provider instructs the patient on use. There are also video instructions accessible at www.Novo-Pulse.com in the Device Training section of our Knowledge Center.

What HCPCS code is used for the NovoPulse® MKX-1 products?

E0762.

What is the current cost of the NovoPulse® MKX-1?

NovoPulse® MKX-1 has an MSRP of $4950.

What are the maximum units of service allowed for HCPCS E0762?

One.

Who should we contact if we have questions regarding the use of the NovoPulse® MKX-1?

You can reach out to our team at contact@Novo-Pulse.com or call us at 952-893-1700.

How should we code our procedures which may be involved in the use of the NovoPulse® MKX-1?

Procedure coding should be based on medical necessity, procedures, and supplies provided to the patient. Physicians should report all surgical and medical services performed and are responsible for determining which CPT code most appropriately describes the work performed. See further details in the REIMBURSEMENT section of our KNOWLEDGE CENTER.

Are there any contraindications to the use of the NovoPulse® MKX-1?
Studies conducted to date do not suggest any long-term adverse effects from the use of devices employing pulsed electromagnetic fields (PEMF). However, long-term effects are unknown. Although no adverse effects have been reported using PEMF, the safety of use during pregnancy and nursing has not been established. This device should not be used by patients with mental or physical conditions which preclude compliance with the device instructions. This device should not be used by individuals who are suffering from epilepsy or other medical complications. Cardiac pacemakers may be adversely affected by exposure to PEMF. This device should not be used by individuals with implanted cardiac pacemakers without consulting their physician. The safety and effectiveness of this device on individuals lacking skeletal maturity have not been established.
Can we possibly expect any adverse reactions to use of the NovoPulse® MKX-1?

Contraindications to the use of the NovoPulse®

Studies conducted to date do not suggest any long-term adverse effects from the use of devices employing pulsed electromagnetic fields (PEMF). However, long-term effects are unknown. Although no adverse effects have been reported using PEMF, the safety of use during pregnancy and nursing has not been established. This device should not be used by patients with mental or physical conditions which preclude compliance with the device instructions. This device should not be used by individuals who are suffering from epilepsy or other medical complications. Cardiac pacemakers may be adversely affected by exposure to PEMF. This device should not be used by individuals with implanted cardiac pacemakers without consulting their physician. The safety and effectiveness of this device on individuals lacking skeletal maturity have not been established.

General risks and complications arising from application of NovoPulse® include the following potential risks and safety considerations:

  • Contact burn may occur if careful consideration and monitoring is not taken in the application of direct contact to the skin and especially in joint areas of the body that do not have much body fat (i.e., knee, foot, ankle, arms).
  • Extra caution should be taken if the patient is susceptible to a burn from heat therapy due to:
    • The presence of an underlying disease.
    • If the patient has had a prior surgery to the region heat is applied, or
    • If the patient applies the heat for over 30 minutes at a time.
ORDER NOW
CONTACT US
ORDER NOW
CONTACT US